Details are still unclear. However, the administration—along with Pfizer and AstraZeneca, the two companies to sign on—promises the storefront will offer deeply discounted drugs directly to Americans. The deal allows the manufacturers to avoid import tariffs. 

The FDA has finalized new Class I recalls related to ongoing safety concerns with Boston Scientific’s Accolade family of pacemakers. A software update is now available to help address the issue, and an additional update is already in the works.

Reps. Diana Harshbarger and Blake Moore recently introduced the Radiology Outpatient Ordering Transmission (ROOT) Act after bipartisan members of the U.S. Senate did the same in May. 

Massachusetts primary care providers are reportedly sending patients to imaging centers in New Hampshire, which lacks a CON law and offers more affordable options. 

The U.S. Department of Health and Human Services said the additional notices were sent in error. A union representing federal workers is challenging the firings, arguing that President Donald Trump lacks the authority to permanently eliminate jobs during a government shutdown. 

President Donald Trump said the shutdown was an opportunity to cut more federal jobs, and it appears he’s made good on that threat. HHS confirmed that reduction-in-force notices were sent to “nonessential” workers as the agency moves to bare-bones operations. 

As the United States continues to move toward quality-based care, ACOs need to rethink the way they attribute care to cardiologists and other members of the heart team. 

What good is AI in healthcare if it doesn’t improve financial margins? The question is getting posed in the C-suites of provider organizations and insurance companies.